Related Experiment Video

Updated: Aug 23, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Cardiac amyloidosis presenting as pseudo-hypertrophic cardiomyopathy

Alexander Papachan1, Karen Sliwa, A Gildenhuys

  • 1Department of Cardiology, Chris Hani-Baragwanath Hospital, Johannesburg, South Africa.

Cardiovascular Journal of South Africa : Official Journal for Southern Africa Cardiac Society [And] South African Society of Cardiac Practitioners
|July 20, 2004
PubMed

Insights

Cardiac amyloidosis and hypertrophic cardiomyopathy can both cause excessive heart muscle thickening. This case highlights a rare instance where cardiac amyloidosis closely mimicked hypertrophic cardiomyopathy, necessitating a biopsy for definitive diagnosis.

Area of Science:

  • Cardiology
  • Cardiovascular Pathology

Background:

  • Cardiac amyloidosis and hypertrophic cardiomyopathy are distinct cardiac conditions.
  • Both can lead to myocardial hypertrophy, observable via echocardiography.
  • Differentiating these conditions is crucial for appropriate patient management.

Observation:

  • This report details a specific case where cardiac amyloidosis presented with echocardiographic findings highly suggestive of hypertrophic cardiomyopathy.
  • The clinical presentation and imaging characteristics were unusually similar between the two pathologies.
  • Standard diagnostic methods were insufficient for clear differentiation in this instance.

Findings:

  • The study identified a challenging case of cardiac amyloidosis.
  • The condition mimicked hypertrophic cardiomyopathy to a significant degree.
  • An endomyocardial biopsy was ultimately required to confirm the diagnosis of cardiac amyloidosis.

Implications:

  • This case underscores the importance of considering cardiac amyloidosis in the differential diagnosis of myocardial hypertrophy, even when symptoms align with hypertrophic cardiomyopathy.
  • Advanced diagnostic procedures, such as endomyocardial biopsy, may be essential in ambiguous cases.
  • Accurate diagnosis is critical for guiding targeted therapy and improving patient outcomes in cardiac pathologies.

More Related Videos

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...